TrialThe journal of headache and pain2022

Quantity changes in acute headache medication use among patients with chronic migraine treated with eptinezumab: subanalysis of the PROMISE-2 study.

Robert P Cowan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.